Clinical management of advanced gastric cancer: The role of new molecular drugs

doi:10.3748/wjg.v20.i40.14537

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 40

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12483)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

798

WORD

368

HTML

8145

Tables (1-5)

265

Sum=9576

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1558

Download

1349

Sum=2907

Oct 28, 2014 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 28, 2014; 20(40): 14537-14558
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14537

Table 2 Phase II trials of epidermal growth factor receptor tyrosine kinase inhibitors for advanced gastric cancer and gastro-esophageal junction cancers

Author/trial	Phase	Setting	Regimen	Patients (n)	RR	OS (mo)	TTP (mo)
NCT00237900[86], 2010	II	Neoadjuvant	CF + G + RT	80	-	42% (3-yr)	-
SWOG 0127[89], 2006	II	1^st line	Erlotinib 150 mg/d	44 (GEJ)	9% (GEJ)	6.7 (GEJ)	-
SWOG 0127[89], 2006	II	1^st line	Erlotinib 150 mg/d	26 (stomach)	0% (stomach)	3.5 (stomach)	-

C: Cisplatin; F: 5 fluorouracil; G: Gefitinib; RT: Radiotherapy; RR: Response rate; OS: Overall survival; TTP: Time to progression; GEJ: Gastro-esophageal junction.

Citation: Vita FD, Martino ND, Fabozzi A, Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V, Sforza V, Marano L, Auricchio A, Galizia G, Ciardiello F, Orditura M. Clinical management of advanced gastric cancer: The role of new molecular drugs. World J Gastroenterol 2014; 20(40): 14537-14558
URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14537.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14537